Jose Merino, ESC 2019 – Radiofrequency Treatment for Atrial Fibrillation
We spoke to Dr Jose Merino (Director, Arrhythmia and Robotic Electrophysiology Unit, Hospital General Universitario La Paz, Madrid, Spain) about the use of radiofrequency treatment for patients with atrial fibrillation, and the advantages of high-power short-duration point-by-point radiofrequency treatment. He also gives his recommendations of how physicians might incorporate these findings into the routine management of patients with atrial fibrillation.
Speaker’s Disclosures: Jose Merino has research and educational contracts with Abbott, Medtronic, Biosense, Boston Scientific, Biotronik, and Microport.
1. What are the limitations with point-by-point radiofrequency application for pulmonary vein isolation in patients with atrial fibrillation? (0:05)
2. What advantages have you found with using high-power, short-duration point-by-point radiofrequency treatment? (1:51)
3. How should physicians incorporate these findings into their routine management of atrial fibrillation? (3:50)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with the Arrhythmia Alliance (A-A) at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
Share this Video
Related Videos In Atrial Fibrillation
World Heart Rhythm Week: Considerations and challenges in arrhythmia
It’s World Heart Rhythm Week 2023! Learn about key considerations for managing and treating arrhythmias, ongoing research and the importance of seeking medical advice for syncope.
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!